F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome-Reference-Cited by-同舟云学术

F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome

Published:2011-12 Issue:12 Volume:52 Page:2287-2297
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

De Felice Claudio,Signorini Cinzia,Durand Thierry,Oger Camille,Guy Alexandre,Bultel-Poncé Valérie,Galano Jean-Marie,Ciccoli Lucia,Leoncini Silvia,D'Esposito Maurizio,Filosa Stefania,Pecorelli Alessandra,Valacchi Giuseppe,Hayek Joussef

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference55 articles.

1. Rett syndrome is caused by mutation in X-linked MECP2, encoding methyl-CpG-binding protein 2;Amir;Nat. Genet.,1999

2. Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835;Cardaioli;J. Submicrosc. Cytol. Pathol.,1999

3. A case report: bone marrow mesenchymal stem cells from a Rett syndrome patient are prone to senescence and show a lower degree of apoptosis;Squillaro;J. Cell. Biochem.,2008

4. Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study;De Felice;Chest.,2010

5. Progressive cardiac dysautonomia observed in patients affected by classic Rett syndrome and not in the preserved speech variant;Guideri;J. Child Neurol.,2001

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial;Antioxidants;2023-03-14

2. F₄-neuroprostanes and F₂-dihomo-isoprostanes: biomarkers and bioactive oxylipins;OCL;2023

3. Omega-3 nutritional intervention as therapeutic co-adjuvant approach to improve Rett syndrome clinical and biochemical features;Modulation of Oxidative Stress;2023

4. Oral Feeding of an Antioxidant Cocktail as a Therapeutic Strategy in a Mouse Model of Rett Syndrome: Merits and Limitations of Long-Term Treatment;Antioxidants;2022-07-20

5. Sirtuins as potential therapeutic targets for mitigating OxInflammation in typical Rett syndrome: plausible mechanisms and evidence;Redox Experimental Medicine;2022-07-01